Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-07-20 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,895 $6.32 $25K 73,255
2021-07-20 ROBINS HARLAN S Chief Scientific Officer Sale −1,300 $36.81 $48K 71,955
2021-07-20 ROBINS HARLAN S Chief Scientific Officer Sale −2,595 $37.82 $98K 69,360
2021-07-20 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,895 109,060
2021-07-19 ROBINS HARLAN S Chief Scientific Officer Option exercise +3,895 $6.32 $25K 73,255
2021-07-19 ROBINS HARLAN S Chief Scientific Officer Sale −1,273 $36.70 $47K 71,982
2021-07-19 ROBINS HARLAN S Chief Scientific Officer Sale −2,622 $37.33 $98K 69,360
2021-07-19 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −3,895 112,955
2021-07-19 Palaniappan Jyoti SVP, Diagnostics, T-Detect Option exercise +651 $22.55 $15K 9,809
2021-07-19 Palaniappan Jyoti SVP, Diagnostics, T-Detect Sale −651 $36.12 $24K 9,158
2021-07-19 Palaniappan Jyoti SVP, Diagnostics, T-Detect Option exercise · Stock Option (Right to Buy) −651 104,393
2021-07-14 GRIFFIN MICHELLE RENEE Director Option exercise +2,500 $7.80 $20K 4,004
2021-07-14 GRIFFIN MICHELLE RENEE Director Sale −2,500 $36.80 $92K 1,504
2021-07-14 GRIFFIN MICHELLE RENEE Director Option exercise · Stock Option (Right to Buy) −2,500 67,000
2021-07-12 ROBINS CHAD M CEO and Chairman Sale −1,501 $38.24 $57K 1,716,960
2021-07-08 ADAMS R MARK Chief Operating Officer Sale −2,254 $36.30 $82K 54,979
2021-07-07 ADAMS R MARK Chief Operating Officer Sale −871 $39.42 $34K 57,233
2021-07-07 Cohen Chad M Chief Financial Officer Option exercise +10,000 $6.55 $66K 31,604
2021-07-07 Cohen Chad M Chief Financial Officer Sale −6,486 $38.17 $248K 25,118
2021-07-07 Cohen Chad M Chief Financial Officer Sale −3,514 $39.20 $138K 21,604

Page 43 of 120 · 2,386 trades